FTO-mediated m6A methylation of PKM2 promotes HCC progression by accelerating the generation of translation products and conversely, FTO knockdown induces G0/G1 phase blockage and inhibits tumor proliferation and growth in vivo [248]. The gene discussed is PKM; the disease is hepatocellular carcinoma.